抗胞漿型磷脂酶A2(PLA2G4)單克隆抗體
Anti-Cytosolic Phospholipase A2 (PLA2G4) Monoclonal Antibody
c-PLA2; cPLA2; PLA2G4A; Phospholipase A2, Cytosolic; Phospholipase A2,Group IV(Cytosolic,Calcium-Dependent); Phosphatidylcholine 2-acylhydrolase; Lysophospholipase
產品包裝(模擬)
產品包裝(模擬)
Human THP1 cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 10μg/ml mouse Anti-human PLA2G4 Monoclonal Antibody (Catalog FAB624Hu02, red histogram) or Isotype control antibody (Catalog IS067-Mu02, green histogram), followed by 1μg/ml FITC-conjugated Anti-mouse IgG Secondary Antibody (Catalog SAA544Mu18).
通過ISO 9001、ISO 13485質量體系認證
用法
Flow cytometry: 10μg/ml;
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過一年。避免反復凍融。
贈品
增值服務
相關產品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPB624Hu02 | 胞漿型磷脂酶A2(PLA2G4)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB624Hu01 | 胞漿型磷脂酶A2(PLA2G4)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB624Hu01 | 胞漿型磷脂酶A2(PLA2G4)多克隆抗體 | WB; IHC |
| PAB624Hu02 | 胞漿型磷脂酶A2(PLA2G4)多克隆抗體 | WB; IHC |
| LAB624Hu71 | 胞漿型磷脂酶A2(PLA2G4)多克隆抗體(生物素標記) | IHC |
| MAB624Hu21 | 胞漿型磷脂酶A2(PLA2G4)單克隆抗體 | WB,IHC |
| MAB624Hu22 | 胞漿型磷脂酶A2(PLA2G4)單克隆抗體 | IHC |
| FAB624Hu02 | 抗胞漿型磷脂酶A2(PLA2G4)單克隆抗體 | FCM |
| FAB624Hu04 | 抗胞漿型磷脂酶A2(PLA2G4)單克隆抗體 | FCM |
| FAB624Hu06 | 抗胞漿型磷脂酶A2(PLA2G4)單克隆抗體 | FCM |
參考文獻
| 雜志 | 參考文獻 |
| BIOMEDICINE & PHARMACOTHERAPY | The synergistic mechanism of total saponins and flavonoids in Notoginseng? Safflower pair against myocardial ischemia uncovered by an integrated?…[Pubmed: 32739736] |